Tyra Biosciences, Inc.TYRANASDAQ
LOADING
|||
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 |
|---|---|---|---|---|---|
| Revenue Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Gross Profit Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EBITDA Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Net Income Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| EPS Diluted Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Weighted Average Shares Growth | +37.34% | +37.03% | +13.61% | +1.50% | +1.35% |
| Weighted Average Shares Diluted Growth | +37.34% | +37.03% | +13.61% | +1.50% | +1.35% |
| Dividends per Share Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Operating Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Free Cash Flow Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Receivables Growth | +0.00% | +0.00% | +0.00% | +0.00% | +15.79% |
| Inventory Growth | +0.00% | +0.00% | +0.00% | +0.00% | +0.00% |
| Asset Growth | +59.67% | +60.97% | -15.14% | -18.08% | -20.69% |
| Book Value per Share Growth | +18.73% | +22.60% | -26.96% | -20.84% | -23.61% |
| Debt Growth | +3.37% | -4.22% | -5.63% | -5.88% | -6.32% |
| R&D Expense Growth | +17.78% | +7.27% | +46.15% | +36.02% | +12.21% |
| SG&A Expenses Growth | +25.90% | +52.59% | +34.52% | +29.05% | +26.54% |